STOCK TITAN

AvePoint (NASDAQ: AVPT) trust plans Rule 144 sale of 5,176 shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AvePoint, Inc. insider entity Brian M Brown Rev Trust filed to sell common stock under Rule 144. The notice covers a planned sale of 5,176 shares of AvePoint common stock, with an indicated aggregate value of $67,590.28, on or after July 29, 2026 on NASDAQ.

The shares derive from a restricted stock grant received from the issuer as compensation on July 7, 2026. Over the prior three months, the same trust reported sales of 8,369, 31,631, and 4,824 AvePoint shares for total proceeds of $108,828.96, $417,028.16, and $63,094.17, respectively.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 5,176 shares Common stock covered by Rule 144 notice for sale on or after July 29, 2026
Planned sale value $67,590.28 Aggregate value of 5,176 AvePoint common shares to be sold
Restricted stock grant date 07/07/2026 Compensation grant that is the source of the 5,176 shares
Sale on July 14, 2026 8,369 shares; $108,828.96 AvePoint shares sold by Brian M Brown Rev Trust during prior 3 months
Sale on July 15, 2026 31,631 shares; $417,028.16 AvePoint shares sold by Brian M Brown Rev Trust during prior 3 months
Sale on July 28, 2026 4,824 shares; $63,094.17 AvePoint shares sold by Brian M Brown Rev Trust during prior 3 months
Rule 144 regulatory
"insider entity Brian M Brown Rev Trust filed to sell common stock under Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock grant financial
"The shares derive from a restricted stock grant received from the issuer as compensation"
A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.
compensation financial
"restricted stock grant received from the issuer as compensation on July 7, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does AvePoint (AVPT) disclose in this Rule 144 filing?

AvePoint reports that Brian M Brown Rev Trust filed a Rule 144 notice to sell 5,176 shares of AvePoint common stock, valued at $67,590.28, beginning on or after July 29, 2026 on NASDAQ.

How many AvePoint (AVPT) shares are covered by the planned Rule 144 sale?

The planned Rule 144 transaction covers 5,176 shares of AvePoint common stock, with an indicated aggregate value of $67,590.28, expected to be sold on or after July 29, 2026 on NASDAQ.

What is the source of the AvePoint (AVPT) shares being sold under Rule 144?

The shares come from a restricted stock grant awarded by AvePoint as compensation on July 7, 2026. The filing lists this grant as the acquisition method for the 5,176 AvePoint common shares covered by the planned sale.

What AvePoint (AVPT) share sales occurred in the past three months by the same trust?

Over the past three months, Brian M Brown Rev Trust sold 8,369, 31,631, and 4,824 AvePoint shares, receiving $108,828.96, $417,028.16, and $63,094.17, respectively, on July 14, 15, and 28, 2026.

On which market are the AvePoint (AVPT) Rule 144 shares expected to be sold?

The Rule 144 notice states that the 5,176 AvePoint common shares are expected to be sold on the NASDAQ market, with an indicated aggregate value of $67,590.28 as of the planned sale date of July 29, 2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature